GoodRx Holdings (GDRX) EBT (2019 - 2026)

GoodRx Holdings (GDRX) has 8 years of EBT data on file, last reported at $5.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBT fell 66.17% year-over-year to $5.6 million; the trailing twelve-month figure through Mar 2026 stood at $45.5 million (down 4.86% YoY), and the FY2025 full-year result was $56.5 million, up 79.71% from the prior year.
• EBT eased to $5.6 million in Q1 2026, from $14.2 million in the prior quarter.
• In the past five years, EBT ranged from a high of $19.6 million in Q2 2025 to a low of -$46.6 million in Q3 2023.
• A 5-year average of $872588.2 and a median of $6.1 million in 2025 frame the typical range for EBT.
• Across the five-year window, EBT sank 2154.52% in 2022 and soared 5588.74% in 2025, its largest moves.
• Tracing GDRX's EBT over 5 years: stood at -$4.7 million in 2022, then plunged by 419.18% to -$24.6 million in 2023, then soared by 146.31% to $11.4 million in 2024, then increased by 24.4% to $14.2 million in 2025, then plunged by 60.27% to $5.6 million in 2026.
• Business Quant data shows GDRX's EBT at $5.6 million in Q1 2026, $14.2 million in Q4 2025, and $6.1 million in Q3 2025.